DIFFDX-MELANOMA
Castle Biosciences Incorporated
| Research |
OneLook
Acronym Finder
|
| Serial Number | 90309462 |
| Registration Number | 6604225 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | James D. Petruzzi |
Timeline
| 2020-11-03 | Date of First Use |
| 2020-11-10 | Application Filed |
| 2021-01-08 | Location: NEW APPLICATION PROCESSING |
| 2021-01-08 | Status: Live/Pending |
| 2021-01-09 | Transaction Date |
| 2021-12-28 | Trademark Registered |
Trademark Applicants & Owners
| Owner: |  Castle Biosciences Incorporated |
| Address | 820 S. Friendswood Drive, Suite 201 Houston DE 77546 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
 Application | MULTI | 2020-11-10 |
 Drawing | JPEG | 2020-11-10 |
| Specimen | JPEG | 2020-11-10 |
Attorney of Record
Good, Services, and Codes
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0441 | Providing medical diagnostic testing services for diagnostic and prognostic purposes; and providing medical information |
| GS0441 | Providing medical diagnostic testing services to dermatologists, surgeons, and oncologists for diagnostic and prognostic purposes for dermatologic melanoma, namely genetic expression profiling and gene sequencing using a neural network, artificial intelligence-designed algorithm relating to dermatological melanoma, and providing medical information based on the expression |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2021-01-09 | 1 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2021-04-19 | 2 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2021-04-20 | 3 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2021-04-20 | 4 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2021-04-20 | 5 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2021-10-18 | 6 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2021-10-18 | 7 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2021-10-18 | 8 TEME I:Incoming Correspondence |
| APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER | 2021-11-18 | 9 CNTA O:Outgoing Correspondence |
| ASSIGNED TO LIE | 2021-11-18 | 10 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2021-11-19 | 11 PREV O:Outgoing Correspondence |
| REGISTERED-SUPPLEMENTAL REGISTER | 2021-12-28 | 12 R.SR A:Allowance for Publication |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2022-09-13 | 13 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2022-09-13 | 14 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2022-09-13 | 15 TCCA I:Incoming Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 